WB result of Apolipoprotein A1/ApoA1 Recombinant Rabbit mAb
Primary antibody: Apolipoprotein A1/ApoA1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: human serum lysate 5 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 30 kDa
Observed MW: 23 kDa
Product Details
Product Details
Product Specification
Host | Rabbit |
Antigen | Apolipoprotein A1/ApoA1 |
Synonyms | Apolipoprotein A-I, Apo-AI, ApoA-I |
Immunogen | Synthetic Peptide |
Location | Secreted |
Accession | P02647 |
Clone Number | S-979-25 |
Antibody Type | Recombinant mAb |
Isotype | IgG |
Application | WB |
Reactivity | Hu |
Predicted Reactivity | Pr, Or, Gor |
Purification | Protein A |
Concentration | 0.5 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
application | dilution | species |
WB | 1:1000 |
Background
Apolipoprotein A1 (ApoA1) is a crucial protein component of plasma lipoproteins that plays diverse essential functions in the human body. ApoA1 is the major structural protein of high-density lipoproteins (HDL). It is primarily responsible for transporting cholesterol from body tissues to the liver for metabolism and excretion, a process known as reverse cholesterol transport. It possesses anti-atherogenic properties, helping to reduce the risk of cardiovascular diseases. Elevated ApoA1 levels may be observed in diseases such as atherosclerosis, diabetes, hyperlipoproteinemia, and liver dysfunction. Long-term alcohol consumption, the use of contraceptives, menopause, and long-term estrogen use among women may also lead to increased ApoA1 levels.
Picture
Picture
Western Blot
